QUANTUM MATERIALS CORPORATION has a steadfast vision that advanced technology is the solution to global issues related to cost, efficiency and increasing energy usage. Quantum dot semiconductors enable a new level of performance in a wide array of established consumer and industrial products, including low cost flexible solar cells, low power lighting and displays and biomedical research applications. Quantum Materials Corporation will invigorate these markets through cost reduction by replacing lab based experiments with volume manufacturing methods to establish a growing line of innovative high performance products.
*** Note to Readers. We at Trinity Alliance, LLP and GenesisNanoTech, have been following this company for over 3 years now. We are pleased to share their vision with all of you at this time. If you would like more information, please feel free to contact this author at:
Quantum Materials Corporation is a development stage nanotechnology and advanced materials company. We perceive an opportunity to acquire a significant amount of the nanomaterials market by commercializing a low cost high volume tetrapod quantum dot production process based on our exclusive license agreement with William Marsh Rice University and on additional proprietary processes and specialized knowledge that has been developed by the company and through our agreement with Access2Flow, a Netherlands based consortium focused on continuous flow chemistry. Our objective is to commercialize our high volume nanomaterials production processes and to use these materials to enable advanced and disruptive technologies that depend on a ready source of low cost materials in order for these technologies to become commercially viable.
SOLTERRA RENEWABLE TECHNOLOGIES, INC., a wholly owned subsidiary of QMC, is singularly positioned to lead the development of truly sustainable and cost-effective solar technology by introducing a new dimension of cost reduction by replacing silicon wafer-based solar cells with low-cost, highly efficient 3rd Generation, Quantum Dot-based solar cells.
SEC 10-K for year ending June 2012. Here is the link: http://t.co/VhbnIEWz
Invited speaker at IdTechEx Printed Electronics USA 2012 . Our topic is “Quantum Dots: The Future is Now” The date is Dec. 5th at the Santa Clara Convention Center. If you will be attending either the conference or just the Trade Show, please let me know. Mr. Squires will be available for business related meetings.
Invited Speaker at the Emerging Molecular Diagnostics Partnering Forum on Feb 11-12 just prior to Molecular Medicine Tri-Conference Feb 12-13 (Moscone, SF) where we will for the first time be an Exhibitor. This is a tremendous opportunity because our quantum dots can fulfill so many needs in pharma and biomedicine. Mr. Squires topic is “Flow Chemistry Process Biocompatible Inorganic High Quantum Yield Tetrapod Quantum Dots For The Next Generation of Diagnostic Assays, Multiplexed Drug Delivery Platforms and POC Devices” Mr. Squires will again be available for business-related meetings.
QMC is in early stage discussions with a worldwide manufacturer/distributor/retailer of consumer goods concerning participation in the development of quantum dot consumer products that could result in two or more possible product collaborations for retail mass production and distribution. This would provide QMC and Solterra with an experienced partner in design, production, marketing and sale outlets for new consumer products. Further research and discussions are needed and industrial and commercial applications of these products could be developed independently of any alliance.
QMC has a NDA and is in discussions with a large molecular biology company currently successfully marketing recombinant proteins to researchers to functionalize QMC TQD to their own recombinant proteins, antibodies, aptamers, and peptides as value added product to sell to researchers in the life sciences. QMC is actively pursuing this same biotech market for other companies amenable to non-exclusive licensing of our quantum dots for research purposes or joint venture for development of advanced diagnostic tools delivering instant results at low cost or the use of our TQD as a drug delivery platform.
We are a public company traded OTC as QTMM
Quantum Dots, R2R, Nanotechnology, Solar, Biomedical, Nanobio